Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析

◆英語タイトル:Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH227948FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nanjing Pharmaceutical Co Ltd (600713) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nanjing Pharmaceutical Co Ltd (NPC) focuses on the distribution of a wide range of pharmaceutical products and other products. It provides a range of pharmaceutical supply chain services and health chain services. NPC also provides traditional chinese medicine, logistics services and rent and property management. It offers its products to hospitals, pharmacies, community health institutions, chain pharmacies and rural township hospitals, clinics and other non-public medical institutions and commercial distribution enterprises. The company provides its services to Anhui, Jiangsu, Hubei, Sichuan, Yunnan and Fujian provinces covering several cities across China. NPC is headquartered in Nanjing, Jiangsu, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nanjing Pharmaceutical Co Ltd – Key Facts
Nanjing Pharmaceutical Co Ltd – Key Employees
Nanjing Pharmaceutical Co Ltd – Key Employee Biographies
Nanjing Pharmaceutical Co Ltd – Major Products and Services
Nanjing Pharmaceutical Co Ltd – History
Nanjing Pharmaceutical Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nanjing Pharmaceutical Co Ltd – Business Description
Business Segment: Main Business
Overview
Performance
Business Segment: Other Business
Overview
Performance
Geographical Segment: Anhui
Performance
Geographical Segment: Fujian
Performance
Geographical Segment: Hubei
Performance
Geographical Segment: Jiangsu
Performance
Geographical Segment: Other
Performance
Geographical Segment: Other Regions
Performance
Nanjing Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nanjing Pharmaceutical Co Ltd – Strengths
Nanjing Pharmaceutical Co Ltd – Weaknesses
Nanjing Pharmaceutical Co Ltd – Opportunities
Nanjing Pharmaceutical Co Ltd – Threats
Nanjing Pharmaceutical Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nanjing Pharmaceutical Co Ltd, Key Facts
Nanjing Pharmaceutical Co Ltd, Key Employees
Nanjing Pharmaceutical Co Ltd, Key Employee Biographies
Nanjing Pharmaceutical Co Ltd, Major Products and Services
Nanjing Pharmaceutical Co Ltd, History
Nanjing Pharmaceutical Co Ltd, Subsidiaries
Nanjing Pharmaceutical Co Ltd, Key Competitors
Nanjing Pharmaceutical Co Ltd, Ratios based on current share price
Nanjing Pharmaceutical Co Ltd, Annual Ratios
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Nanjing Pharmaceutical Co Ltd, Interim Ratios
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cascade Metrix LLC:製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that commercializes an automated POC blood analyzer for critical care. The company provides product portfolio such as novel micro-volume IV extension kits; and automated glucose monitoring systems, among others. It also provides a revo …
  • Tradewinds Corporation Berhad:戦略・SWOT・企業財務分析
    Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China General Nuclear Power Corp (1816):企業の財務・戦略的SWOT分析
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • Temasek Holdings (Private) Ltd:企業の戦略・SWOT・財務分析
    Temasek Holdings (Private) Ltd - Strategy, SWOT and Corporate Finance Report Summary Temasek Holdings (Private) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ClearPoint Neuro Inc (CLPT):企業の財務・戦略的SWOT分析
    Summary ClearPoint Neuro Inc (ClearPoint) is a medical equipment company. It develops and commercializes platforms for performing invasive surgical procedures. Its products include ClearPoint system a surgical platform, that enables delivery of therapies treat a neurological diseases and disorders b …
  • Bankinter, S.A.:企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Sebia SA:企業の製品パイプライン分析2018
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Black Knight Inc (BKI):企業の財務・戦略的SWOT分析
    Black Knight Inc (BKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company provides smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It of …
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Carillion plc:戦略・SWOT・企業財務分析
    Carillion plc - Strategy, SWOT and Corporate Finance Report Summary Carillion plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Lumberg Connect GmbH:企業の戦略的SWOT分析
    Lumberg Connect GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Filtration Group Corp:企業の戦略的SWOT分析
    Filtration Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Wallenstam AB (WALL B):企業の財務・戦略的SWOT分析
    Summary Wallenstam AB (Wallenstam) is a construction company that offers building and property management solutions. The company's services include commercial and residential properties development, housing programs, property investment and management, urban development, property ownership services, …
  • Opthea Ltd (OPT)-医療機器分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Federal Grid Company of Unified Energy System (FEES):電力:M&Aディール及び事業提携情報
    Summary Federal Grid Company of Unified Energy System (FGC UES), a subsidiary of Rosseti, is an energy company. It operates and manages unified national electricity transmission grid system. The company transmits electricity to distribution grid companies, large commercial end customers and retail e …
  • Piksel, Inc.:企業のM&A・事業提携・投資動向
    Piksel, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Piksel, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆